Details of the Drug Formulations

General Information of Drug (ID: DMUR64T)

Drug Name
Lesinurad Drug Info
Synonyms
LESINURAD; 878672-00-5; RDEA594; Zurampic; RDEA 594; UNII-09ERP08I3W; RDEA-594; 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid; 09ERP08I3W; AK323774; C17H14BrN3O2S; 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid; 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid; 2-(5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid
Indication
Disease Entry ICD 11 Status REF
Hyperuricaemia 5C55.Y Approved [1] , [2]
Cross-matching ID
PubChem CID
53465279
ChEBI ID
CHEBI:90929
CAS Number
878672-00-5
TTD ID
D0C3SW
VARIDT ID
DR01130
INTEDE ID
DR0926
ACDINA ID
D00354

Full List of Drug Formulations Containing This Drug

Lesinurad 200 mg tablet
Company Formulation ID FDA Description
Ironwood Pharmaceuticals F11368 Lactose monohydrate; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Triacetin; Crospovidone, unspecified; Hypromellose 2910 (5 mpa.s); Microcrystalline cellulose
AstraZeneca F11369 Lactose monohydrate; Magnesium stearate; Water; Cellulose, microcrystalline; Crospovidone (15 mpa.s at 5%); Hypromelloses
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7673).
2 ClinicalTrials.gov (NCT01493531) Combining Lesinurad With Allopurinol in Inadequate Responders. U.S. National Institutes of Health.